ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

University of Kansas Cancer Center Receives NCI Center Designation

July 13, 2012

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985

ASCO Breaks Ground For New HQ.

August 4, 2006

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007